Nazan Cinislioğlu

Nazan Cinislioğlu

Auto-generated profile, based on publicly available information

Nazan Cinislioğlu

Erzurum Regional Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2024 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
ACAhmet Emre Cinislioğlu
Ahmet Emre Cinislioğlu
NCNazan Cinislioğlu
Nazan Cinislioğlu
MÖMetin İsHak Öztürk
Metin İsHak Öztürk
FAFatih Akkaş
Fatih Akkaş
TATugay Aksakallı
Tugay Aksakallı
AKAteş Kadıoğlu
Ateş Kadıoğlu
Study demonstrated that antibiotic resistance in the treatment of uncomplicated urinary tract infections varies by geographical region. We believe this comprehensive, national prospective study will provide valuable insights for clinicians planning empirical treatment for uncomplicated urinary tract infections.

7 November 2025 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
NCNazan Cinislioglu
Nazan Cinislioglu
SYSibel Iba Yilmaz
Sibel Iba Yilmaz
TATugay Aksakalli
Tugay Aksakalli
Background: Crimean–Congo haemorrhagic fever (CCHF) is a severe tick-borne viral infection with a high mortality rate. The multi-inflammatory index (MII), consisting of MII-1, MII-2 and MII-3, has been proposed as a prognostic biomarker in infectious diseases. However, its role in CCHF prognosis remains unclear. Methods: This retrospective observational study analysed 290 CCHF patients admitted to Erzurum Regional Training and Research Hospital between January 2019 and September 2024. The MIIs were calculated from blood samples obtained on the day of hospital admission. Patients were categorized based on mortality outcomes, and logistic regression and receiver operating characteristics curve analyses were conducted to assess the predictive value of the MIIs. Results: Mortality occurred in 9.31% of patients, with significantly higher MII-1, MII-2 and MII-3 levels in non-survivors. MII-1 showed the highest predictive accuracy (area under the curve 0.846, sensitivity 88%, specificity 75%). No significant difference was found in ribavirin administration between survivors and non-survivors. Conclusions: MIIs, particularly MII-1, serve as independent predictors of mortality in CCHF patients. Early evaluation of MII levels may aid risk stratification and clinical decision-making. Future studies should explore the dynamic changes in these indices and their impact on treatment outcomes.

30 June 2022 in Yeni Üroloji Dergisi
Verified
Journal Article
Open access
PDF file
ACAhmet Emre Cinislioğlu
Ahmet Emre Cinislioğlu
EŞEmre Şam
Emre Şam
NCNazan Ci̇ni̇sli̇oğlu
Nazan Ci̇ni̇sli̇oğlu
SDSaban Oguz Demirdogen
Saban Oguz Demirdogen
IKİbRahim Karabulut
İbRahim Karabulut
IÖİsA Özbey
İsA Özbey
Objective: In this study, we aimed to investigate whether the anxiety caused by the COVID-19 pandemic on healthcare professionals with different duties, such as doctors, nurses, medical secretaries, and medical staff, causes erectile dysfunction (ED). Material and Methods: In between 1 May 2020 and 1 August 2020, volunteering male health workers who had regular sexual intercourse at least once a week for the last six months and who had not previously worked in COVID-19 clinics were included in the study. Before and 4 weeks after working in COVID-19 clinics, erectile function was determined by the International Index of Erectile Function-5 (IIEF-5) form. The Hamilton Anxiety Rating Scale (HAS) was used to evaluate anxiety disorders and their severity. Results: A total of 218 male health caregivers were included in the study. Among these, 56 (25.7%) were doctors, 81 (37.2%) were nurses, 46 (21.1%) were medical secretaries and 35 (16.1%) were the medical staff. The mean HAM-A score of the doctors measured 4 weeks after having worked in a COVID-19 clinic (3,32±4,68) was observed to be significantly higher compared to that measured before working (28,43±14,05) (p<0.001). The mean IIEF-5 scores of the doctors measured 4 weeks after having worked in a COVID-19 clinic (16,34±4,11) was observed to be significantly lower compared to that measured before working (22,29±2,35) (p<0.001). Conclusion: Our results indicate that healthcare professionals working in COVID-19 clinics have increased anxiety and ED, and physicians are affected more than the other healthcare professionals. Keywords: COVID-19, health professionals, erectile dysfunction, anxiety, hamilton anxiety scale

22 September 2026 in Sağlık Bilimlerinde Değer
Verified
Journal Article
Closed access
NCNazan Cinislioğlu
Nazan Cinislioğlu
NPNurdan Pür
Nurdan Pür
Aim: Brucellosis is a significant zoonotic infection, particularly prevalent in developing countries, with the potential to cause multisystem involvement. This study aimed to evaluate the clinical, laboratory, and treatment outcomes of patients diagnosed with brucellosis in Erzurum, an endemic region.Material and Methods: This retrospective study included 627 adult patients diagnosed with brucellosis at the Infectious Diseases Clinic of Erzurum City Hospital between January 2020 and June 2024. Demographic data, clinical findings, laboratory values, organ involvement, treatment regimens, and treatment outcomes were obtained by reviewing patient records. Diagnosis was based on standard serum agglutination test (≥1:160), blood culture results, and clinical data.Results: The mean age of the patients was 45.9 ± 17.1 years, and 54.1% were male. The most frequently reported risk factors were consumption of unpasteurized milk and dairy products (71.0%) and a history of livestock farming (68.3%). The most common clinical symptoms were fatigue (92.8%), fever (80.9%), and joint pain (75.3%). 57.9% of cases were in the acute form of brucellosis. The most common complications were osteoarticular involvement (34.1%), genitourinary involvement (7.2%), and neurobrucellosis (4.2%). The most commonly used general treatment regimen was doxycycline plus rifampicin (41.6%), with an overall treatment success rate of 98.6%.Conclusion: Brucellosis remains a significant public health problem in endemic regions such as Erzurum. Early diagnosis, appropriate combination therapies, and relapse prevention strategies are critical for effective disease management.

29 July 2026 in Acta Tropica
Verified
Journal Article
Closed access
NCNazan Cinislioğlu
Nazan Cinislioğlu
AYAyten Yanık
Ayten Yanık

12 August 2026 in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
NCNazan Cinislioğlu
Nazan Cinislioğlu
NPNurdan Pür
Nurdan Pür
NANurten Nur Aydın
Nurten Nur Aydın
Amaç: Stenotrophomonas maltophilia doğal direnç mekanizmaları ve sınırlı tedavi seçenekleri nedeniyle önemli bir nozokomiyal patojen haline gelmiştir. Bu çalışma S. maltophilia bakteriyemisi olgularında antimikrobiyal duyarlılık paternlerini, klinik özellikleri ve mortaliteyle ilişkili faktörleri değerlendirmeyi amaçlamaktadır. Gereç ve Yöntemler: Bu retrospektif gözlemsel çalışmaya, 2020-2025 yılları arasında Erzurum Şehir Hastanesinde kan kültürlerinde Stenotrophomonas maltophilia izole edilen 18 yaş ve üzeri erişkin bireyler dâhil edilmiştir. Klinik veriler hastane kayıtlarından elde edilmiş; antimikrobiyal duyarlılık sonuçları ise European Committee on Antimicrobial Susceptibility Testing (EUCAST) ve Clinical and Laboratory Standards Institute (CLSI) standartlarına göre değerlendirilmiştir. Bulgular: Toplam 221 hastanın yaş ortalaması 64,6±20,3 yıl olup %53,3’ü erkekti. Mortalite oranı %34,8 olarak saptandı. Mortalite, ileri yaş, yoğun bakım yatışı (%93,5), komorbidite varlığı (%94,8) ve invaziv cihaz kullanımı ile anlamlı derecede yüksek bulunmuştur (p